Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesBariatric & Obesity ManagementPremera Bluecross Bariatric Surgery Coverage Updat…
    Ask Trek AI about this page

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    CurrentPremera BluecrossPolicy 7.01.516

    Bariatric Surgery

    Customize your policy alerts

    Sign up for Premera Bluecross Policy 7.01.516 alerts

    Get alerted when Policy 7.01.516 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Policy governing medical necessity, coverage criteria, documentation, and coding guidance for bariatric (weight loss) surgical procedures for Premera Bluecross members.

    Policy Summary
    PayerPremera Bluecross
    PolicyBariatric Surgery
    Policy CodePolicy 7.01.516
    Change TypeNo material changes
    Effective DateAug 1, 2026
    Last ReviewJul 27, 2026
    Next Review DateAug 1, 2026
    Key ActionObtain prior authorization with documentation that medical necessity criteria are met, including BMI, comorbidities, participation in a ≥3-month physician‑administered weight‑reduction program, and mental health clearance by a licensed provider.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    BMI ≥40Class III threshold
    BMI 35–39.9Class II threshold
    3 months (90 days)Weight‑reduction program
    HbA1c ≥7T2D glycemic threshold
    50% EBW / 20% TWLInadequate weight loss (revision)

    Coverage Criteria and Medical Necessity

    Primary coverage for adults with class II/III obesity

    Covered when ALL of the following criteria are met:

    BMI criteria

    • Comorbid examples: Established coronary heart disease (history of angina, angioplasty, coronary artery surgery, or myocardial infarction), other atherosclerotic disease (e.g., AAA, peripheral arterial disease), uncontrolled or medically refractory hypertension (despite ≥2 medications of different classes), type 2 diabetes that is uncontrolled (HbA1c ≥7), moderate to severe obstructive sleep apnea after failure of CPAP/BiPAP/oral applianceHbA1c ≥7 for diabetes

      OSA failure defined elsewhere

    Conservative management and program participation: Participation in a physician-administered weight reduction program lasting at least 3 continuous months within 12 months before surgery (documentation of active participation required)3 months
    Policy Summary
    PayerPremera Bluecross
    PolicyBariatric Surgery
    Policy CodePolicy 7.01.516
    Change TypeNo material changes
    Effective DateAug 1, 2026
    Last ReviewJul 27, 2026
    Next Review DateAug 1, 2026
    Key ActionObtain prior authorization with documentation that medical necessity criteria are met, including BMI, comorbidities, participation in a ≥3-month physician‑administered weight‑reduction program, and mental health clearance by a licensed provider.
    SourceLink
    On This Page
    Coverage Criteria and Medical NecessityCoding and ReimbursementPrior Authorization, Documentation, and Operational NotesBackground and Clinical ContextDefinitions and Key TermsPolicy Revision History

    Structured commercial programs acceptable if supervised by a provider

    Mental health clearance: Mental health evaluation and clearance by a licensed mental health provider to rule out contraindicating disorders, inability to provide informed consent, or inability to comply with pre- and post-surgical requirements; a surgeon/provider summary letter alone is insufficient
    Facility and surgeon requirements: Procedure should be performed by a surgeon with specialized bariatric training at a facility with a comprehensive bariatric surgery program; any device used must be FDA-approved and used per labeled indications

    Adults with T2 diabetes and class I obesity

    Covered when ALL of the following are met:

    BMI and diabetes: Class I obesity (BMI 30–34.9 kg/m2 or ≥27.5–32.4 kg/m2 for an Asian individual) AND inadequately controlled type 2 diabetes (HbA1c ≥7) despite lifestyle changes and antidiabetic medicationsHbA1c ≥7
    Weight program: Participation in a physician-administered weight reduction program lasting at least 3 continuous months within the 12 months before surgery OR documentation of participation in a structured program (e.g., Weight Watchers, Jenny Craig) supervised by the healthcare provider3 months

    A surgeon summary letter alone is not sufficient

    Mental health evaluation and clearance by a licensed mental health provider to rule out contraindicating disorders and inability to comply; a physician's summary letter alone is not sufficient documentation

    Revision, conversion, and reoperation criteria

    Revision or conversion may be covered for complications or inadequate weight loss when specific criteria are met.

    Revision for complications: Revision or removal (including replacement or repair) of a prior bariatric procedure is medically necessary to address perioperative or late complications such as band erosion, slippage, leakage, herniation, intractable nausea/vomiting not correctable by adjustment, component malfunction not repairable, non-absorption causing hypoglycemia or malnutrition, obstruction, staple-line failure (e.g., gastrogastric fistula), stricture, or ulceration

    May be billed with unlisted CPT 43659 for some procedures

    Revision for inadequate weight loss: Conversion or reoperation for inadequate weight loss may be considered medically necessary when ALL of the following are met: previous bariatric surgery was at least 2 years prior; there is documentation of compliance with the prescribed postoperative nutrition and exercise program; and the individual failed to achieve adequate weight loss defined as <50% excess body weight loss (EBW) or <20% total weight loss (TWL)≥2 years since prior surgery; failure = <50% EBW or <20% TWL

    Inadequate weight loss due to individual noncompliance is not medically necessary indication for revision

    Conversion for reflux after sleeve gastrectomy: Conversion of sleeve gastrectomy to Roux-en-Y gastric bypass for symptomatic GERD is medically necessary when reflux is documented by abnormal 24-hour pH monitoring or endoscopic esophagitis performed after sleeve gastrectomy, and symptoms persist despite optimal medical therapy (an 8-week trial of daily proton pump inhibitor therapy)8 weeks PPI trial

    General Medical Necessity and Preoperative Requirements

    Covered when ALL of the following are met:

    Documentation of conservative management: Medical record documents failure to respond to conservative measures for weight reduction; active participation in a formal weight reduction program including documentation of weight, dietary regimen, and exercise may be requiredsee BMI thresholds

    Some centers require documented supervised programs

    Mental health clearance: Mental health evaluation and clearance by a licensed mental health provider to rule out contraindicating disorders, inability to provide informed consent, or inability to comply; a letter from a healthcare provider alone is insufficient
    Age appropriateness and medical necessity: The requested bariatric surgical procedure must be considered medically necessary for the individual's age under the member's benefit plan

    Procedure Selection Considerations

    Selection considerations and documented indications:

    BMI considerations: Individuals with BMI ≥50 kg/m2 generally require a bariatric procedure to achieve greater weight loss; adjustable gastric banding, which yields less weight loss, is more suitable for individuals with BMI <50 kg/m2BMI 50 kg/m2
    Procedure risk/benefit: Malabsorptive procedures (e.g., biliopancreatic diversion/duodenal switch) produce greater weight loss but carry higher risk of nutritional complications; procedure choice must be individualized to treatment goals and risks

    Adolescent-specific Criteria

    Adolescents considered for bariatric surgery should meet ALL relevant items:

    Weight-based criteria: Guideline thresholds vary but commonly parallel adult criteria (examples include BMI ≥35 kg/m2 with comorbidities up to BMI ≥50 kg/m2); some guidelines use percentiles (e.g., >120% or >140% of the 95th percentile)variable

    See society guidance for specific pediatric thresholds

    Maturity and psychosocial readiness: Emphasis on developmental maturity, psychosocial stability, informed consent, family support, and demonstrated ability to adhere to healthy dietary and activity habits; Endocrine Society suggests Tanner stage 4–5 and near-final adult height as considerations in some guidance

    Multidisciplinary evaluation recommended; device labelling may restrict use in <18 yrs

    Preoperative and procedural clinical criteria

    Clinical principles and preoperative expectations referenced in this section:

    Conservative management before surgery: Individuals should have tried and failed conservative measures (dietary and lifestyle interventions) prior to consideration of bariatric surgery; documentation of attempts should be reviewedfailure of conservative measures

    See Background and documentation requirements

    Hiatal hernia repair guidance: Repair of symptomatic paraesophageal (type II–IV) hiatal hernias is recommended; repair of type I (sliding) hiatal hernia without reflux is not necessarysymptomatic paraesophageal or presence of reflux

    Fundoplication may be beneficial when repairing type II–IV hernias

    Preoperative EGD is recommended for symptomatic individuals; routine preoperative EGD may be performed at the surgeon's discretion and when performed should use high-quality technique and document findingssymptomatic indication preferred; surgeon discretion allowed

    ASMBS 2021 and AGA 2024 guidance referenced

    Class III obesity (BMI ≥40 kg/m2)

    Adults with Class III obesity

    Class III bariatric surgery coverage: Adults (≥18 years) with BMI ≥40 kg/m2 are candidates for bariatric surgery (e.g., Roux-en-Y gastric bypass, adjustable gastric banding, sleeve gastrectomy, biliopancreatic diversion/duodenal switch, or SADI-S); evidence demonstrates substantial weight loss and improvements in comorbidities and net health outcomesBMI ≥40 kg/m2

    Supported by RCTs, observational studies, and systematic reviews

    Class II obesity (BMI 35–39.9 kg/m2)

    Adults with Class II obesity

    Class II bariatric surgery coverage: Adults (≥18 years) with BMI 35–39.9 kg/m2 may be treated with bariatric surgery (Roux-en-Y, adjustable banding, sleeve gastrectomy, biliopancreatic diversion/duodenal switch, or SADI-S) when evidence of benefit and comorbidity improvement existBMI 35–39.9 kg/m2

    Evidence includes RCTs, observational studies, and systematic reviews

    Class I obesity (BMI 30–34.9 kg/m2) with T2D

    Adults with Class I obesity and type 2 diabetes

    Class I with T2D coverage: Adults with BMI 30–34.9 kg/m2 and type 2 diabetes may be considered for bariatric surgery (procedures as above) when diabetes is inadequately controlled by optimal lifestyle and medical therapy; systematic reviews of RCTs show greater diabetes remission and HbA1c reductions with surgeryBMI 30–34.9 kg/m2 + T2D

    Quality of evidence graded low to very low; balance benefits vs short-term surgical risks

    Lower-BMI adults without T2D

    Adults with BMI <35 kg/m2 without T2D

    Lower-BMI without T2D: For adults with BMI <35 kg/m2 and no type 2 diabetes, evidence is insufficient to determine long-term risk–benefit of bariatric surgery; routine coverage is not supported by the evidence in this populationBMI <35 kg/m2

    Small RCTs and case series exist but long-term net benefit unclear

    Revision procedures

    Revision bariatric surgery

    Revision surgery coverage: Revision bariatric surgery (including conversions) is supported by systematic reviews, cohort data, and registries showing satisfactory weight loss and comorbidity improvement; complication rates are reported but benefits may outweigh risks when appropriately selectedN/A

    Evidence indicates revision procedures can be safe and efficacious

    Adolescents

    Adolescents with obesity

    Adolescent coverage: Adolescents with severe obesity who meet guideline criteria and are carefully selected (considering developmental stage and psychosocial readiness) may receive bariatric surgery (commonly RYGB, adjustable banding, or sleeve gastrectomy); evidence shows significant weight loss and comorbidity reductionVariable (consider BMI >50 kg/m2 or severe comorbidities); see society guidance

    Most guidelines reserve surgery for severe comorbidities or very high BMI and recommend multidisciplinary evaluation

    Preadolescent children

    Preadolescent children

    Preadolescent coverage: No studies focused solely on preadolescent children; limited cohort data suggest possible benefit from LSG in selected young children, but evidence is insufficient to determine net health outcome—coverage decisions require careful consideration and specialty center expertiseN/A

    Further comparative studies required

    Hiatal hernia repair during bariatric surgery

    Hiatal hernia repair with bariatric surgery

    Hiatal hernia repair: When a preoperative diagnosis of hiatal hernia exists with clinical indications for repair, concurrent hiatal hernia repair during bariatric surgery (e.g., during sleeve gastrectomy) is considered medically necessary and has been shown to improve GERD remission and reduce certain complications versus SG alonePreoperative diagnosis of hiatal hernia with clinical indications

    No evidence to support repair for incidental intraoperative findings

    Preoperative EGD

    Esophagogastroduodenoscopy (EGD) with bariatric surgery

    Preoperative EGD can identify upper GI findings that change management in about 20% of patients; routine preoperative EGD is not mandated but may be performed at the surgeon's discretion—EGD is recommended for symptomatic individuals and should document indications and findings using high-quality techniqueN/A

    Comparative evidence on routine vs selective EGD is insufficient; use AGA/ASMBS guidance for high-quality endoscopy

    Pediatric/adolescent coverage indications (society summaries)

    Adolescent/pediatric criteria (society summaries):

    Adolescent indications: Referral/evaluation for metabolic/bariatric surgery should be offered when pediatric BMI percentile thresholds and comorbidity criteria are met; evaluation by a multidisciplinary specialty center is recommendedBMI >120% of 95th percentile with a major comorbidity OR BMI >140% of 95th percentile

    AAP and ASMBS recommend referral for adolescents ≥13 years meeting severe obesity criteria

    Adolescent metabolic/bariatric surgery criteria (ASMBS/Endocrine Society)

    Professional society guidance (ASMBS and Endocrine Society) regarding adolescent indications and considerations:

    ASMBS adolescent recommendation: Children and adolescents with BMI >120% of the 95th percentile and a major co-morbidity, or BMI >140% of the 95th percentile, should be considered for metabolic/bariatric surgery after multidisciplinary specialty center evaluationBMI >120% or >140% of 95th percentile

    ASMBS 2022 statement

    ASMBS adolescent considerations: Do not use Tanner stage or bone age as referral requirements; screen/treat common micronutrient deficiencies (e.g., vitamin B), and assess developmental delay/autism/syndromic obesity on a case-by-case multidisciplinary basisN/A

    ASMBS guidance

    Endocrine Society pediatric guidance: Suggest bariatric surgery only if child has attained Tanner 4 or 5 and near-final adult height, BMI >40 kg/m2 or BMI >35 kg/m2 with extreme comorbidities, persistent extreme obesity despite lifestyle modification (with/without pharmacotherapy), stable family psychological evaluation, access to an experienced pediatric bariatric center, and demonstrated ability to adhere to healthy habitsTanner 4/5; BMI thresholds as stated

    Endocrine Society (2008, updated 2017)

    EGD preoperative and surveillance criteria (ASMBS and gastroenterology societies)

    ASMBS and gastroenterology society statements on upper GI endoscopy before and after bariatric surgery:

    Preoperative EGD consideration: Routine preoperative EGD is justifiable and should be done at the surgeon's discretion because clinical evaluation by symptoms alone does not reliably diagnose or rule out GERD and upper GI abnormalities are frequently found even in asymptomatic patientsN/A

    ASMBS 2021 position statement

    Postoperative EGD surveillance after SG: It is reasonable to perform EGD on patients ≥3 years after sleeve gastrectomy to evaluate for Barrett's esophagus, with consideration of repeat surveillance every 5 years thereafter>=3 years post-SG; then every 5 years

    ASMBS recommendation pending longer-term studies

    High-quality EGD practice elements: When EGD is indicated, ensure appropriate indication, adequate visualization (mucosal cleansing/insufflation), use high-definition white-light systems, inspect in anterograde and retroflexed views, and document findings using established classifications and standard terminologyN/A

    AGA 2024 practice update

    The policy lists several bariatric procedures that are considered investigational and are excluded from favorable coverage conclusions. Examples include biliopancreatic diversion or bypass without duodenal switch, Billroth II / single-anastomosis (mini) gastric bypass, laparoscopic gastric plication (LGCP), long-limb gastric bypass (>150 cm), two-stage procedures, vagal nerve blocking (VBLOC/Maestro), and a range of endoscopic primary or revision procedures such as endoscopic sleeve gastroplasty (ESG), intragastric balloons (e.g., ORBERA, Obalon, Spatz3), restorative obesity surgery endoluminal (ROSE), transoral outlet reduction (TORe), aspiration devices (e.g., AspireAssist), natural orifice transluminal endoscopic surgery (NOTES), and duodenal-jejunal sleeves (endoscopic gastrointestinal liners).

    A documented mental health evaluation and clearance by a licensed mental health provider is required to rule out contraindicating psychiatric disorders and inability to comply with perioperative requirements; the policy explicitly states that a letter from a healthcare provider alone is insufficient to meet this requirement.

    Guidance on hiatal hernia repair notes that repair of a type I (sliding) hiatal hernia in the absence of reflux disease is not necessary. Symptomatic paraesophageal (type II–IV) hernias should be repaired, and fundoplication may be considered when repairing type II–IV hernias, but incidental sliding hernia without reflux does not by itself indicate repair.

    The evidence is insufficient to conclude that bariatric surgery provides a long-term net health benefit for adults with BMI <35 kg/m2 who do not have type 2 diabetes, and the policy states that preadolescent children lack focused studies demonstrating net benefit; thus these populations are not supported for routine surgical coverage based on current evidence.

    The policy summarizes explicitly listed contraindications drawn from professional guidance, including medically correctable causes of obesity, untreated or poorly controlled substance abuse, concurrent or planned pregnancy, current eating disorder, and inability to adhere to postoperative recommendations and mandatory lifestyle changes.

    The Medicare National Coverage Determination (NCD) from 2006 is summarized: it considers RYGB, LAGB, and BPD/DS reasonable and necessary for Medicare beneficiaries with BMI >35 kg/m2 plus comorbidity, and it lists as noncovered the following procedures for all Medicare beneficiaries: open vertical-banded gastroplasty, laparoscopic vertical-banded gastroplasty, open sleeve gastrectomy, laparoscopic sleeve gastrectomy, and open adjustable gastric banding.

    The references section compiles guideline and evidence citations but does not specify additional explicit coverage exclusions beyond those articulated elsewhere in the policy.

    The policy document states that it does not apply to Medicare Advantage and that coverage decisions remain subject to each member's benefit plan limits and conditions.

    The policy specifies that bariatric surgery is considered not medically necessary for individuals with BMI <35 kg/m2 who do not have T2D, and for all individuals with BMI <30 kg/m2 (except where Asian-specific exceptions apply). This general exclusion is reiterated and tied to the insufficiency of long-term evidence in lower-BMI adults without T2D.

    The policy states that routine liver biopsy during obesity surgery is not medically necessary in the absence of preoperative signs or symptoms of liver disease (for example, elevated liver enzymes or hepatomegaly).

    The policy clarifies that revision or conversion surgery is not considered medically necessary when the only reason is inadequate weight loss due to the individual's noncompliance with postoperative nutrition and exercise recommendations.

    Vertical-banded gastroplasty (VBG; CPT 43842) is described as a procedure that is largely no longer performed in the U.S. because of high rates of complications and reoperations; it is not included on the ASMBS list of endorsed procedures and is therefore not an endorsed option in contemporary practice.

    For adults with BMI <35 kg/m2 who do not have type 2 diabetes, the policy concludes the evidence is insufficient to establish long-term benefit of bariatric procedures; consequently such procedures are not supported as medically necessary in this population.

    The Endocrine Society advises against bariatric surgery for preadolescent children and recommends caution for pregnant or breastfeeding adolescents and those planning pregnancy within two years of surgery. Professional society guidance emphasizes Tanner stage, near-final height, psychosocial readiness, and avoidance of surgery in patients with unresolved substance abuse or eating disorders.

    The references section catalogs randomized trials, systematic reviews, and guideline documents used to support the policy recommendations; this compendium of evidence does not itself list additional not-medically-necessary conditions beyond those specified in the policy text.

    Coding and Reimbursement

    Covered CPT Codes (selected)CPTCovered
    43845Biliopancreatic bypass with duodenal switch (open)
    43659Unlisted laparoscopic procedure, used here for duodenal switch (lap) per policy
    43644Laparoscopic Roux-en-Y gastric bypass
    43645Open Roux-en-Y gastric bypass
    43846Roux-en-Y gastroenterostomy (short limb ≤150 cm)
    43770Laparoscopic adjustable gastric banding
    43775Sleeve gastrectomy
    43999Unlisted procedure, stomach (used for SADI-S per policy)
    Investigational / Not Covered CodesCPT | HCPCSNot Covered
    43847Long-limb gastric bypass procedure (>150 cm) — investigational
    43842Vertical-banded gastroplasty (VBG) — not medically necessary
    43843Laparoscopic gastric plication (LGCP) — investigational
    43889Endoscopic sleeve gastroplasty (ESG) — investigational
    0813TSpatz3 intragastric balloon (listed as example) — investigational
    C9785Transoral outlet reduction (TORe) HCPCS — investigational
    Unlisted procedure codes referencedCPT
    44799Unlisted procedure, intestine (listed as possible unlisted code)
    44238Unlisted laparoscopy procedure (listed as possible unlisted code)
    Covered CPT Codes (selected from list)CPT
    0813TEsophagogastroduodenoscopy, flexible, transoral, with volume adjustment of intragastric bariatric balloon (e.g., Spatz3).
    43290Esophagogastroduodenoscopy, flexible, transoral; with deployment of intragastric bariatric balloon.
    43291Esophagogastroduodenoscopy, flexible, transoral; with removal of intragastric bariatric balloon(s).
    43644Laparoscopy, surgical, gastric restrictive procedure; with gastric bypass and Roux-en-Y gastroenterostomy (roux limb 150 cm or less).
    43645Laparoscopy, surgical, gastric restrictive procedure; with gastric bypass and small intestine reconstruction to limit absorption
    Additional CPT / Unlisted CodesCPT
    43659Unlisted laparoscopy procedure, stomach / Laparoscopy, surgical, gastric restrictive procedure; placement of adjustable gastric restrictive device (eg, gastric band and subcutaneous port components).
    43772Laparoscopy, surgical, gastric restrictive procedure; removal of adjustable gastric restrictive device component only.
    43773Laparoscopy, surgical, gastric restrictive procedure; removal and replacement of adjustable gastric restrictive device component only.
    43774Laparoscopy, surgical, gastric restrictive procedure; removal of adjustable gastric restrictive device and subcutaneous port components.
    43775Laparoscopy, surgical, gastric restrictive procedure; longitudinal gastrectomy (i.e., sleeve gastrectomy).
    43842Gastric restrictive procedure, without gastric bypass, for morbid obesity; vertical-banded gastroplasty.
    43843Gastric restrictive procedure, without gastric bypass, for morbid obesity; other than vertical-banded gastroplasty.
    43845Gastric restrictive procedure with partial gastrectomy, pylorus-preserving duodenoileostomy and ileoileostomy (50 to 100 cm common channel) to limit absorption (biliopancreatic diversion with duodenal switch).
    43846Gastric restrictive procedure, with gastric bypass for morbid obesity; with short limb (150 cm or less) Roux-en-Y gastroenterostomy.
    43847Gastric restrictive procedure, with gastric bypass for morbid obesity; with small intestine reconstruction to limit absorption.
    1–10 of 18
    1/2
    HCPCS CodesHCPCS
    C9784Gastric restrictive procedure, endoscopic sleeve gastroplasty... (code terminated effective 01/01/26).
    C9785Endoscopic outlet reduction, gastric pouch application, with endoscopy and intraluminal tube insertion, if performed, including all system and tissue anchoring components.
    Gastric bypass (open) CPTCPT
    43846Open gastric bypass (short limb ≤150 cm) — restrictive and malabsorptive component
    Gastric bypass (laparoscopic) CPTCPT
    43644Laparoscopic gastric bypass
    Adjustable gastric banding CPTCPT
    43770Laparoscopic adjustable gastric banding
    Sleeve gastrectomy and duodenal switch CPTCPT
    43775Open or laparoscopic sleeve gastrectomy
    43845Biliopancreatic diversion with duodenal switch (duodenal switch specific)
    Biliopancreatic diversion / long-limb bypass CPTCPT
    43847Biliopancreatic diversion (Scopinaro procedure) / long-limb gastric bypass (used for variations)
    Vertical-banded gastroplasty CPTCPT
    43842Vertical-banded gastroplasty (VBG)
    Laparoscopic malabsorptive CPTCPT
    43645Laparoscopic malabsorptive procedure (non-specific)
    Gastric plication CPTCPT
    43843Gastric restrictive procedure, without gastric bypass, other than VBG (commonly used for gastric plication)
    Unlisted CPTCPT
    43999Unlisted procedure, stomach (used for single anastomosis duodeno-ileal bypass with sleeve gastrectomy)
    SADI-S coding (unlisted)CPT
    43999Unlisted procedure, stomach; used for SADI-S because no specific CPT code exists
    FDA-approved bariatric devices (PMA-labeled)mixed
    Spatz3 Adjustable BalloonPMA-approved intragastric adjustable balloon (max placement 8 months)
    Obalon intragastric balloonPMA-approved intragastric balloon (BMI 30–40; max placement 6 months)
    AspireAssist SystemPMA-approved aspiration device for long-term use in obese adults >22 years (BMI 35–55)
    ORBERA intragastric balloonPMA-approved intragastric balloon (BMI 30–40; max placement 6 months)
    LAP-BAND Adjustable Gastric BandPMA-approved adjustable gastric band (indicated for severe obesity per labeling)
    REALIZE Adjustable Gastric BandPMA-approved adjustable gastric band (indicated for morbidly obese adults per labeling)
    Medicare coverage stancemixed
    Medicare NCD listRYGB, LAGB, BPD/DS considered reasonable and necessary for Medicare beneficiaries with BMI >35 plus comorbidity; open and laparoscopic sleeve gastrectomy and open adjustable gastric banding listed as noncovered for Medicare
    Coding notes and listed CPT/HCPCS referenced in history and coding updatesmixed
    C9784HCPCS code added previously; noted terminated effective January 1, 2026
    C9785HCPCS code added July 1, 2023
    0312TCPT code previously included; removed effective 01/01/23 and term dated in coding section
    0313TCPT code previously included; removed effective 01/01/23 and term dated in coding section
    0314TCPT code previously included; removed effective 01/01/23 and term dated in coding section
    0315TCPT code previously included; removed effective 01/01/23 and term dated in coding section
    0316TCPT code previously included; removed effective 01/01/23 and term dated in coding section
    0317TCPT code previously included; removed effective 01/01/23 and term dated in coding section
    43290New CPT code added
    43291New CPT code added
    1–10 of 17
    1/2
    inv-55: BMI thresholds (class I/II/III with Asian adjustments)
    Class I (adult) — standardBMI 30.0–34.9 kg/m2 (Asian-adjusted: 27.5–32.4 kg/m2)
    Class II (adult) — standardBMI 35.0–39.9 kg/m2 (Asian-adjusted: 32.5–37.4 kg/m2)
    Class III (adult) — standardBMI ≥40.0 kg/m2 (Asian-adjusted: ≥37.5 kg/m2)
    inv-56: OSA severity (AHI) and CPAP/BiPAP failure definition
    OSA severity categories (AHI)Moderate: AHI 15–30 events/hour; Severe: AHI >30 events/hour
    CPAP/BiPAP/oral appliance failure definitionDefined as residual AHI ≥15 or inability to tolerate CPAP/BiPAP ≥4 hours per night for ≥5 nights per week
    OSA mild category (for reference)Mild: AHI 5 to ≤15 events/hour; Normal: AHI <5 events/hour
    inv-57: BMI examples and notes (e.g., BMI ≥50 noted as indication)
    Consideration example — adults with comorbidityAdults with BMI ≥35 kg/m2 are commonly considered for bariatric surgery when obesity-related comorbidities are present
    High-BMI example influencing procedure selectionIndividuals with BMI ≥50 kg/m2 generally need a bariatric procedure to achieve greater weight loss; adjustable gastric banding is more suitable for BMI <50 kg/m2
    BMI noted as indication for needBMI ≥50 kg/m2 is specifically called out as indicating the need for a bariatric procedure
    inv-58: Diabetes test thresholds (HbA1c, FBS, GTT)
    HbA1c diagnostic thresholdHemoglobin A1c ≥6.5%
    Fasting blood sugar (FBS) diagnostic thresholdFBS ≥126 mg/dL
    Oral glucose tolerance test (2-hour) thresholdGlucose tolerance test ≥200 mg/dL
    inv-59: BMI thresholds summary (Class I/II/III)
    CDC Class IBMI 30.0 to <35.0 kg/m2
    CDC Class IIBMI 35.0 to <40.0 kg/m2
    CDC Class IIIBMI ≥40.0 kg/m2
    inv-60: BMI thresholds per society guidance (adult tiers)
    Adult tier — severe obesityBMI ≥40 kg/m2 (eligible for MBS when operative risk acceptable)
    Adult tier — obesity with comorbidityBMI ≥35 kg/m2 with ≥1 severe obesity-related complication remediable by weight loss (e.g., T2D, OSA)
    Adult tier — lower BMI with T2DBMI 30.0–34.9 kg/m2 with inadequately controlled type 2 diabetes despite optimal medical therapy (consider MBS)
    inv-61: Adolescent BMI thresholds (ASMBS and Endocrine Society)
    ASMBS adolescent thresholdsBMI >120% of the 95th percentile with a major comorbidity, or BMI >140% of the 95th percentile (consider for MBS after multidisciplinary evaluation)
    Endocrine Society adolescent thresholdsRecommend consideration only if Tanner stage 4–5, near-final height, and BMI >40 kg/m2 or BMI >35 kg/m2 with extreme comorbidities
    AAP referral thresholdRefer adolescents ≥13 years with severe obesity (BMI ≥120% of 95th percentile) for evaluation at specialty centers

    Prior Authorization, Documentation, and Operational Notes

    Prior Authorization

    Prior authorization required

    Obtain prior authorization before bariatric procedures; the request must demonstrate that medical necessity criteria are met (BMI meeting policy thresholds, relevant comorbidities, completion of required preoperative evaluations, and mental health clearance).

    • Prior authorization is required for listed bariatric procedures and associated CPT/HCPCS codes.
    • Authorization requests must document medical necessity per policy criteria.
    Documentation Required

    Required supporting documentation for authorization

    Include complete supporting documentation with the prior authorization: calculated BMI (with Asian-specific thresholds when applicable), documentation of obesity-related comorbidities, evidence of participation in a physician‑administered weight‑loss program (≥3 continuous months within 12 months pre‑op), and mental health evaluation and clearance by a licensed mental health provider (a surgeon summary letter alone is insufficient).

    • Record member weight and BMI calculation (see BMI calculation guidance).
    • Document program name, dates, and evidence of active participation (weight, diet, exercise).
    • Provide licensed mental health provider evaluation and clearance; a provider summary letter alone does not meet this requirement.
    Billing Rule

    Use applicable procedure codes on authorization

    Reference the applicable CPT/HCPCS codes on authorization requests and claims for the specific bariatric procedure being requested; include unlisted code details when applicable and ensure coding matches the planned technique (open vs laparoscopic) and procedure type.

    • Use listed CPT codes for procedures such as 43644, 43645, 43770, 43775, 43845, 43846, 43847, etc., as appropriate to the procedure.
    • Include HCPCS/CPT modifiers or technique descriptors that reflect open vs laparoscopic approach when relevant.
    Billing Rule

    Unlisted coding for SADI‑S (use 43999)

    For SADI‑S (single anastomosis duodeno‑ileal bypass with sleeve gastrectomy) use unlisted stomach procedure code 43999 for prior authorization and claims because there is no specific CPT code for this procedure.

    • Include a detailed operative description and rationale when submitting 43999 for SADI‑S.
    • Attach intraoperative or surgeon documentation to support use of an unlisted code for clinical review.
    Prior Authorization

    Document BMI and comorbidities for prior auth

    Provide BMI and comorbidity documentation in the authorization request: cite relevant BMI threshold (e.g., BMI ≥40, BMI 35–39.9 with an obesity‑related comorbidity, or BMI 30–34.9 with inadequately controlled T2D) and list documented obesity‑related conditions that support coverage.

    • Document diabetes control (e.g., HbA1c ≥7) when claiming T2D indication.
    • Clearly indicate which policy BMI threshold is being met (including Asian‑specific thresholds when applicable).
    Prior Authorization

    Verify FDA‑labeled device indications for device authorizations

    Confirm device labeling and FDA‑approved indications for implantable bariatric devices when requesting authorization; verify device‑specific eligibility criteria and labeled time limits (e.g., intragastric balloon placement duration and BMI ranges).

    • Match member's BMI and comorbidity profile to device labeled indications (e.g., ORBERA, Spatz3, AspireAssist, LAP‑BAND, REALIZE).
    • Note device‑specific maximum placement durations (e.g., 6–8 months for certain balloons) in the request.
    Note

    Guidelines do not replace payer authorization

    Do not rely on cited professional guideline references alone to determine payer authorization rules; guidelines inform expectations but the policy does not substitute for obtaining company prior authorization per member benefits.

    • Guideline citations (ASMBS, IFSO, ASGE, etc.) inform clinical expectations but do not define payer-specific prior authorization workflows.
    • Providers must request authorization per the health plan's processes and benefit terms.
    Prior Authorization

    Obtain pre‑procedure authorization per plan rules

    Obtain authorization prior to the procedure per member benefit requirements; this policy serves as guidance for Company staff but providers must secure pre‑procedure authorization when required by the plan.

    • Authorization is implied by the policy as the basis for Company coverage determinations.
    • Verify whether the member's plan requires preauthorization and obtain it accordingly.
    Step Therapy

    Document failed conservative therapy (3‑month program)

    Document participation in and failure of conservative measures before surgery: physician‑administered weight‑reduction program of at least three continuous months (within 12 months before surgery) is expected, and for OSA document trial and failure of CPAP/BiPAP or oral appliances when applicable.

    • Evidence of active participation should include weight records, named dietary program, and exercise regimen.
    • For OSA, document polysomnography and definition of CPAP/BiPAP failure (residual AHI ≥15 or inability to tolerate therapy).
    Documentation Required

    Document failed medical weight‑loss attempts

    Before considering surgery, show documentation of failed conservative weight‑loss measures (medical weight loss attempts); some centers may require active participation in a formal supervised program with frequent documentation of weight, diet, and exercise.

    • Include records from structured programs (e.g., Weight Watchers, Jenny Craig) with provider supervision if used.
    • Provide dates and duration of the supervised program within the 12‑month preoperative window.
    Note

    Expect documented dietary/lifestyle interventions prior to surgery

    Convey that dietary and lifestyle interventions are expected before surgery and that bariatric procedures are considered when these conservative measures have failed to achieve needed weight loss.

    • Document prior non‑surgical management attempts and rationale for proceeding to surgery.
    • Ensure conservative therapy efforts are summarized in the medical record submitted for review.
    Prior Authorization

    Specify indication tier by BMI and comorbidity

    Indicate which BMI/comorbidity tier supports the request: class III (BMI ≥40), class II (BMI 35–39.9) with at least one severe obesity‑related comorbidity, or class I (BMI 30–34.9) with inadequately controlled T2D despite optimal therapy.

    • State the specific comorbidity(ies) qualifying the request (e.g., uncontrolled T2D, OSA, NAFLD).
    • If the member is Asian, use adjusted BMI thresholds per policy.
    Note

    Document consideration/role of non‑surgical or short‑term therapies

    When considering non‑surgical or short‑term procedural options (e.g., intragastric balloons), document that these therapies were considered or tried as per guideline context and whether short‑term adjunctive approaches are appropriate to the member's goals.

    • Note that intragastric balloons may be considered for short‑term (~6 months) weight loss alongside lifestyle interventions.
    • If an endoscopic therapy is planned, include documentation of guideline‑based candidacy and monitoring plans.
    Documentation Required

    Include safety monitoring plan for intragastric balloons

    For intragastric balloons, include counseling and monitoring plans in the authorization and medical record because FDA safety communications recommend close monitoring and patient counseling regarding potential serious adverse events (e.g., hyperinflation, pancreatitis, obstruction, premature removal).

    • Document patient counseling on symptoms of life‑threatening complications and a monitoring plan for the duration of balloon treatment.
    • Confirm device brand and labeled maximum placement time in the request.
    Step Therapy

    No specific step‑therapy requirements stated

    No formal step‑therapy protocol is specified in the references; do not assume a payer step‑therapy sequence beyond the policy's expectation of documented conservative management and program participation.

    • References summarize guideline approaches but do not define explicit payer step‑therapy requirements.
    • Authorization decisions are based on documented failure of conservative measures, not a specified step sequence in these references.
    Documentation Required

    Provide supervised program participation dates and evidence

    When documenting program participation history, provide dates and duration of supervised weight‑reduction participation; historically requirements changed from six to three months, so supply current documentation of at least three continuous months (90 days) within 12 months pre‑op.

    • State program start and end dates and the supervising provider or program name.
    • Include weight trend data during the program to show active participation.
    Documentation Required

    Required preoperative documentation for review

    Ensure medical records submitted for authorization include BMI calculation (with Asian‑specific thresholds when applicable), documented comorbid conditions, completion details of a physician‑administered weight‑loss program of ≥3 consecutive months within 12 months pre‑op, and mental health evaluation and clearance by a licensed mental health provider.

    • Include BMI calculation method and source data (weight, height, dates).
    • Provide documentation of program content, duration, and active participation.
    Documentation Required

    Include program details and weight data in records

    When submitting preoperative documentation, include program details (name of program or supervising clinician), specific weight measurements and dates, and calculation of weight‑loss metrics when relevant (percent EWL, percent TWL).

    • Attach program notes showing member weight at program start and end, dietary plan, and exercise regimen.
    • Provide EWL and TWL calculations using provided formulas when applicable.
    Documentation Required

    Provide BMI and weight‑loss calculations

    Include BMI calculations and, when relevant, weight‑loss calculations such as percent excess weight loss (EWL) and percent total weight loss (TWL) in the medical record submitted for authorization or utilization review.

    • Use the policy's BMI calculation guidance and the provided formulas for EWL and TWL.
    • Document preoperative and most recent weights with dates to permit calculation.
    Documentation Required

    Document EGD indication, findings, and impact on planning

    If a preoperative EGD is performed, document the indication (symptoms vs surgeon discretion), findings, and how findings affected management or operative planning; use high‑quality visualization and standard classifications when available.

    • Record whether EGD was performed for symptoms or at surgeon discretion and summarize findings (e.g., large hiatal hernia, peptic ulcer, H. pylori).
    • Document any operative changes or delays resulting from EGD findings.
    Documentation Required

    Document comprehensive preoperative evaluation

    Perform and document a comprehensive preoperative evaluation for weight‑related complications and causes of obesity per guideline recommendations; record factors that affect the recommendation for surgery (medical, psychosocial, developmental for adolescents).

    • Include assessment of comorbid conditions and how surgery is expected to address them.
    • For adolescents, include multidisciplinary evaluation and developmental/readiness documentation.
    Documentation Required

    Include society‑recommended preoperative evaluation elements

    Follow society‑recommended pre‑operative evaluation components in documentation: weight‑related complication assessment, causes of obesity, psychosocial and developmental factors (for adolescents), and factors that affect operative suitability.

    • Cite relevant guideline recommendations used to support clinical decisions in the record.
    • Provide documentation of multidisciplinary input when required.
    Documentation Required

    Justify and document preoperative EGD indication and technique

    When EGD is performed preoperatively, document the indication carefully since routine EGD identifies management‑changing findings in only about 20% of patients; justify routine versus symptom‑guided EGD and record findings using high‑quality technique and established classifications.

    • If routine EGD is performed at surgeon discretion, state the rationale and any findings that altered care.
    • Ensure endoscopy reports document high‑definition visualization and standard terminology per AGA guidance.
    Note

    Reference guideline documents to support documentation

    Cite relevant professional guideline documents (ASMBS, AACE/ACE, AGA, ASGE, VA/DoD, AAP, etc.) in the clinical record to support documentation expectations and preoperative planning when applicable.

    • Include guideline references used to inform the preoperative plan when they support the medical necessity rationale.
    • Do not substitute guideline citation for the required documentation items described in policy.
    Billing Rule

    Confirm member benefits and plan limitations

    Verify member benefit limitations and preauthorization requirements with the member's benefit booklet or customer service prior to submission; coverage is subject to plan limits and conditions and this policy does not apply to Medicare Advantage.

    • Confirm whether the member's plan includes coverage for bariatric procedures and any age or benefit limits.
    • Contact customer service or consult the benefit booklet to confirm authorization workflow and plan‑specific limits.
    Denial Risk

    Do not request coverage for investigational/not‑necessary procedures

    Avoid requesting coverage for procedures listed as investigational or not medically necessary (e.g., vertical‑banded gastroplasty, long‑limb gastric bypass >150 cm, endoscopic primary bariatric procedures, intragastric balloons and certain endoscopic revision procedures) as these are triggers for denial.

    • Do not submit authorization requests for explicitly investigational or not medically necessary procedures per policy.
    • If a procedure is investigational, provide alternative, evidence‑based treatment plan and rationale.
    Documentation Required

    Include licensed mental health evaluation and clearance

    Include a licensed mental health provider evaluation and clearance in the preoperative record; absence of documented mental health assessment and clearance (a provider summary letter alone is insufficient) may trigger denial.

    • Mental health evaluation must rule out contraindicating disorders, inability to consent, or inability to comply with perioperative requirements.
    • Do not rely on surgeon summary letters alone to satisfy this requirement.
    Denial Risk

    Risk of denial for missing conservative management documentation

    Failure to document participation in and active engagement with a structured weight‑loss program (including weight records, dietary program name, and exercise documentation) or lack of documented failure of conservative measures may result in denial of surgical approval.

    • Provide objective evidence of program participation and failure to achieve adequate weight loss with conservative therapy.
    • If structured programs were used, include supervising provider documentation.
    Documentation Required

    EGD indication must be documented when performed

    If preoperative EGD is performed, document the appropriate indication; failure to document a legitimate indication (symptoms or justified surgeon discretion) and associated findings may prompt utilization review or denial.

    • State whether EGD was symptom‑driven or performed at surgeon discretion and summarize findings and their effect on management.
    • Ensure endoscopy reports use standard classifications and adequate visualization techniques.
    Denial Risk

    Routine preoperative EGD may be scrutinized

    Note that routine preoperative EGD changes operative management in only about 20% of cases; when EGD is submitted as routine rather than symptom‑indicated, reviewers may scrutinize its justification and this could affect authorization outcomes.

    • If ordering routine EGD, include rationale for surgeon discretion and any prior symptoms or risk factors prompting the test.
    • Attach the EGD report and explain any management changes resulting from findings.
    Prior Authorization

    Document absence of contraindications (or address them)

    Screen for and document contraindications that could preclude surgery (e.g., medically correctable causes of obesity, untreated or poorly controlled substance abuse, pregnancy/planned pregnancy, active eating disorder, or inability to adhere to postoperative requirements), as their presence may trigger denial.

    • Document treatment or resolution of any medically correctable cause of obesity before proceeding.
    • If contraindications exist, include plans for management or stabilization prior to reconsideration.
    Denial Risk

    Medicare noncoverage may trigger denial for listed procedures

    Be aware Medicare NCD noncoverage listings when authorizing for Medicare beneficiaries: certain procedures (open and laparoscopic sleeve gastrectomy, open adjustable gastric banding, vertical banded gastroplasty) are listed as noncovered for Medicare and may lead to denial under Medicare rules.

    • For Medicare patients, verify NCD applicability and do not expect Medicare coverage for procedures listed as noncovered in the NCD.
    • If treating a Medicare beneficiary, include NCD‑supported procedures and ensure documentation aligns with Medicare criteria.
    Note

    Follow payer operational authorization process (not defined in references)

    References and guideline sections do not state operational prior authorization workflows; providers must follow the payer's operational authorization processes and submit the documentation required by the plan.

    • The policy cites guidelines but does not provide plan‑specific operational steps for authorization.
    • Contact the payer or use the payer's portal/process to submit required documents.
    Denial Risk

    Benefit limitations can cause denial—verify plan specifics

    Coverage decisions are subject to member benefit limits; verify plan‑specific limitations (age, number of procedures, device coverage) prior to submitting an authorization because benefit limits can cause denial.

    • Confirm whether the member's plan excludes certain procedures or devices.
    • If benefit limitations apply, document that the requested service is within plan allowances.

    Background and Clinical Context

    Bariatric surgery is used to treat clinically severe obesity and related complications. The policy frames surgery as appropriate for carefully selected patients who have failed conservative management and who meet specified BMI and comorbidity thresholds. Expected outcomes include substantial and sustained weight loss and improvement or remission of obesity-related comorbidities when performed at accredited centers by experienced surgeons; procedure type and patient selection should be individualized to balance benefits and risks.

    Definitions and Key Terms

    inv-97: Class III obesity definition
    Class III obesity definitionBMI ≥40.0 kg/m2 (Asian-adjusted: ≥37.5 kg/m2)
    Population ageApplies to adults aged ≥18 years
    Relation to coverageClass III obesity meets primary BMI criterion for bariatric surgery coverage when other criteria met
    inv-98: Class II obesity definition
    Class II obesity definitionBMI 35.0–39.9 kg/m2 (Asian-adjusted: 32.5–37.4 kg/m2)
    Qualification noteMay qualify for surgery coverage when at least one obesity-related comorbidity is present
    Evidence basisSupported by RCTs, observational studies, and systematic reviews showing greater weight loss vs nonsurgical therapy
    inv-99: Failure of CPAP/BiPAP definition
    Failure of CPAP/BiPAP definitionResidual AHI ≥15 or inability to tolerate CPAP/BiPAP ≥4 hours per night for ≥5 nights per week
    Context of useApplied when documenting moderate-to-severe OSA that has failed positive airway pressure therapy prior to considering MBS
    OSA severity categories referencedModerate OSA: AHI 15–30; Severe OSA: AHI >30
    inv-100: BMI calculation definition and conversion
    BMI calculation formulaBMI = weight (kg) / [height (m)]^2
    Pounds to kilograms conversionMultiply pounds by 0.45
    Inches to meters conversionMultiply inches by 0.0254
    inv-101: CDC Obesity Classes
    CDC Class IBMI 30 to <35 kg/m2
    CDC Class IIBMI 35 to <40 kg/m2
    CDC Class IIIBMI ≥40 kg/m2
    inv-102: Type I (sliding) hiatal hernia
    Type I (sliding) hiatal herniaGastroesophageal junction migrates above the diaphragm; repair not necessary in absence of reflux disease
    Clinical implicationRoutine repair of asymptomatic sliding hernias generally not indicated
    Evidence strengthModerate-quality evidence supporting nonrepair in absence of reflux
    inv-103: Type II/III/IV (paraesophageal) hiatal hernia
    Type II/III/IV (paraesophageal) hiatal herniaPortion of stomach alongside the esophagus; symptomatic paraesophageal hernias should be repaired
    Surgical considerationFundoplication may be beneficial when repairing type II–IV hernias
    Evidence noteHigh-quality evidence supports repair for symptomatic paraesophageal hernias
    inv-104: SADI-S definition
    SADI-S definitionSleeve gastrectomy creating a smaller tube-shaped stomach combined with a single anastomosis duodeno-ileal bypass of the small intestine; no specific CPT code exists (use 43999)
    Coding implicationUse unlisted procedure code 43999 for claims and authorization
    Procedure descriptionDivides the proximal small intestine just after the stomach and creates a single intestinal anastomosis
    inv-105: Metabolic and bariatric surgery (MBS) definition
    MBS definition (general)Surgical procedures (e.g., sleeve gastrectomy, Roux-en-Y gastric bypass, biliopancreatic diversion with duodenal switch) performed to induce weight loss and improve obesity-related comorbidities
    Selection considerationsProcedure choice individualized by treatment goals, patient risk, and surgeon expertise
    Lifelong managementSevere obesity is a chronic disease requiring long-term management after primary MBS (may include revisional surgery)
    inv-106: Endoscopic bariatric and metabolic therapies definition
    Endoscopic bariatric/metabolic therapiesMinimally invasive endoscopic treatments (e.g., intragastric balloons, endoscopic gastric remodeling) used with lifestyle modification for weight loss
    Indication per ASGE-ESGE 2024Suggested for adults with BMI ≥30 kg/m2 (or BMI 27–29.9 kg/m2 with comorbidity) as adjunct to lifestyle modification
    Typical roleOften considered for short-term weight loss or as adjunct when surgery not appropriate
    inv-107: Esophagogastroduodenoscopy (EGD) definition
    EGD definitionEndoscopic procedure to inspect the upper gastrointestinal tract (esophagus, stomach, duodenum); useful to detect malignancy, hiatus hernia, peptic ulcer disease, H. pylori, and assess distal stomach anatomy
    Preoperative roleDetects conditions that may contraindicate or change operative planning (e.g., large hiatal hernia, peptic ulcer, H. pylori)
    DocumentationWhen performed, EGD should document indication and findings to inform surgical planning
    inv-108: Professional guideline sources cited
    Key professional guideline sources citedASMBS, IFSO, ASGE (with ESGE), SAGES, AACE/ACE, VA/DoD, AAP
    Guideline topics representedIndications for MBS, perioperative nutrition/support, endoscopy guidance, hiatal hernia surgical guidance
    Reference examplesASMBS 2022/2024; ASGE-ESGE 2024; AACE 2022; AAP 2019/2023

    Policy Revision History

    1997-05-05policy_added

    Policy added to Surgery Section as a new policy (initial adoption).

    2000-09-21policy_updated

    Policy updated to include expanded discussion of biliopancreatic bypass and gastric banding; policy statement unchanged.

    2002-06-19policy_updated

    Policy revised to include mini-gastric bypass.

    2003-02-11policy_updated

    Policy revised to include LAP-BAND gastric restrictive procedure as medically necessary (replaced CP.MP.BC.7.01.47).

    2006-10-10policy_updated

    Policy updated after literature search; policy statement expanded to indicate liver biopsy during morbid obesity surgery as not medically necessary.

    2022-11-01policy_updated

    Interim review approved October 10, 2022; endoscopic procedures (TORe, ROSE) listed as investigational and minor edits/formatting changes made; wording standardized from 'patient' to 'individual'.

    2023-04-11annual_review

    Annual review updated policy with literature through January 3, 2023 and added medically necessary indication for individuals with T2 diabetes and class I obesity.

    2023-07-01coding_update

    Coding update added HCPCS codes C9784 and C9785.

    2026-07-27last_reviewLatest

    Policy last revised and reviewed with effective date set to 2026-08-01 reflecting current consolidated updates and administrative refinements.